Related Experiment Video
Updated: Jul 10, 2026

Demystifying Venous Excess Ultrasound (VExUS): Image Acquisition and Interpretation
Published on: May 16, 2025
Part 4: Considerations regarding the medical management of VUR: what have we really learned?
Martin A Koyle1, Anthony A Caldamone
1Department of Urology, The Children's Hospital, Denver, CO 80218, USA. Koyle.Martin@tchden.org
Insights
Prophylactic antibiotics for pediatric vesicoureteral reflux (VUR) may increase antibiotic resistance and have low patient compliance. Re-evaluating VUR management is crucial, considering alternatives like endoscopic injection.
Area of Science:
- Pediatric Urology
- Infectious Disease
- Pharmacology
Background:
- Prophylactic antibiotics are a common initial treatment for pediatric vesicoureteral reflux (VUR) grades I-IV.
- Overuse and misuse of antimicrobials contribute significantly to the rise of antibiotic resistance.
- Limited controlled studies exist on the efficacy of prophylactic antibiotics specifically for VUR.
Purpose of the Study:
- To critically evaluate the current use of prophylactic antibiotics in pediatric VUR.
- To highlight the challenges and disadvantages associated with this treatment approach.
- To advocate for the consideration of alternative VUR management strategies.
Main Methods:
- Review of existing literature on VUR treatment and antibiotic resistance.
- Analysis of the evidence supporting prophylactic antibiotic use in VUR.
- Discussion of patient compliance and antimicrobial resistance concerns.
Main Results:
- Prophylactic antibiotic use in VUR is widespread despite questionable evidence.
- Antimicrobial resistance is a growing concern linked to widespread antibiotic use.
- Patient compliance with prophylactic antibiotic regimens is often suboptimal.
Conclusions:
- The current reliance on prophylactic antibiotics for VUR warrants re-evaluation due to risks of resistance and poor compliance.
- Alternative treatments, such as endoscopic injection, should be explored given the limitations of traditional therapies.
Abstract:
In the treatment of vesicoureteral reflux (VUR), the use of prophylactic antibiotics is most often the first treatment option in children with grades I-IV VUR. Both the overuse and misuse of antimicrobials have accelerated the appearance and spread of antibiotic resistance. There is a lack of controlled studies that address the role and efficacy of prophylactic antibiotic use in the VUR population. Physicians may also be pressured to prescribe antibiotic therapy by patients even in the absence of appropriate indications for use. However, patient reported compliance is often far lower than clinically documented compliance. The associated disadvantages of prophylactic antibiotic use include the development of antimicrobial resistance and patient noncompliance which begs for a re-evaluation of current management patterns of VUR. Considering questionable evidence supporting the use of traditional therapies, new innovations, including endoscopic injection, should be considered as an alternative.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
